Abstract:A detailed study of palmitate metabolism in pancreatic islets subject to different experimental conditions, like varying concentrations of glucose, as well as fed or starved conditions, has allowed us to explore the interaction between the two main plasma nutrients and its consequences on hormone secretion. Palmitate potentiates glucose-induced insulin secretion in a concentration-dependent manner, in a physiological range of both palmitate (0–2 mM) and glucose (6–20 mM) concentrations; at glucose concentrations lower than 6 mM, no metabolic interaction with palmitate was apparent. Starvation (48 h) increased islet palmitate oxidation two-fold, and the effect was resistant to its inhibition by glucose (6–20 mM). Consequently, labelled palmitate and glucose incorporation into complex lipids were strongly suppressed, as well as glucose-induced insulin secretion and its potentiation by palmitate. 2-bromostearate, a palmitate oxidation inhibitor, fully recovered the synthesis of complex lipids and insulin secretion. We concluded that palmitate potentiation of the insulin response to glucose is not attributable to its catabolic mitochondrial oxidation but to its anabolism to complex lipids: islet lipid biosynthesis is dependent on the uptake of plasma fatty acids and the supply of α-glycerol phosphate from glycolysis. Islet secretion of glucagon and somatostatin showed a similar dependence on palmitate anabolism as insulin. The possible mechanisms implicated in the metabolic coupling between glucose and palmitate were commented on. Moreover, possible mechanisms responsible for islet gluco- or lipotoxicity after a long-term stimulation of insulin secretion were also discussed. Our own data on the simultaneous stimulation of insulin, glucagon, and somatostatin by glucose, as well as their modification by 2-bromostearate in perifused rat islets, give support to the conclusion that increased FFA anabolism, rather than its mitochondrial oxidation, results in a potentiation of their stimulated release. Starvation, besides suppressing glucose stimulation of insulin secretion, also blocks the inhibitory effect of glucose on glucagon secretion: this suggests that glucagon inhibition might be an indirect or direct effect of insulin, but not of glucose. In summary, there seems to exist three mechanisms of glucagon secretion stimulation: 1. glucagon stimulation through the same secretion coupling mechanism as insulin, but in a different range of glucose concentrations (0 to 5 mM). 2. Direct or indirect inhibition by secreted insulin in response to glucose (5–20 mM). 3. Stimulation by increased FFA anabolism in glucose intolerance or diabetes in the context of hyperlipidemia, hyperglycemia, and hypo-insulinemia. These conclusions were discussed and compared with previous published data in the literature. Specially, we discussed the mechanism for inhibition of glucagon release by glucose, which was apparently contradictory with the secretion coupling mechanism of its stimulation.

What problem does this paper attempt to address?

The main issue this paper attempts to address is the regulatory role of fatty acid metabolism in the changes of glucose-induced insulin and glucagon secretion in islet cells. Specifically, the study focuses on the effects of palmitic acid (a common free fatty acid) on hormone secretion in islet cells under different experimental conditions (such as different glucose concentrations, fasting, or feeding states). ### Main Issues: 1. **How does fatty acid metabolism affect glucose-induced insulin secretion?** - The study found that palmitic acid within the physiological range (0-2 mM) can enhance glucose-induced insulin secretion, especially when glucose concentration is between 6-20 mM. However, this enhancement is not significant when glucose concentration is below 6 mM. 2. **Changes in fatty acid metabolism during fasting and its impact on hormone secretion?** - After 48 hours of fasting, the oxidation rate of palmitic acid in islet cells increased twofold, and this increase was not inhibited by glucose. In the fasting state, the incorporation of labeled palmitic acid and glucose into complex lipids was significantly reduced, and glucose-induced insulin secretion and its enhancement were also inhibited. The use of the palmitic acid oxidation inhibitor 2-bromostearate can restore the synthesis of complex lipids and insulin secretion. 3. **The effect of fatty acid metabolism on glucagon and somatostatin secretion?** - The secretion of glucagon and somatostatin in islet cells also depends on the synthetic metabolism of palmitic acid, similar to insulin. Fasting not only inhibited glucose-stimulated insulin secretion but also blocked the inhibitory effect of glucose on glucagon secretion, suggesting that the inhibition of glucagon may be a direct or indirect effect of insulin rather than glucose. 4. **The relationship between fatty acid metabolism and islet cell dysfunction?** - The paper discusses the mechanisms of glucotoxicity and lipotoxicity that may occur in islet cells after prolonged stimulation of insulin secretion and how these mechanisms affect the secretion of insulin, glucagon, and somatostatin. ### Conclusion: - Palmitic acid enhances glucose-induced insulin secretion through its synthetic metabolism (rather than mitochondrial oxidation). - Lipid synthesis in islet cells depends on the uptake of plasma free fatty acids and α-glycerophosphate provided by glycolysis. - The secretion of glucagon is regulated by both glucose and insulin, but mainly depends on the action of insulin. - Prolonged hyperglycemia and hyperlipidemia may lead to islet cell dysfunction, thereby affecting the normal secretion of hormones. These conclusions help to understand the important role of fatty acid metabolism in islet cells and provide new perspectives for the study of metabolic diseases such as diabetes.

Regulatory Role of Fatty Acid Metabolism on Glucose-Induced Changes in Insulin and Glucagon Secretion by Pancreatic Islet Cells

High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans

The Regulation and Secretion of Glucagon in Response to Nutrient Composition: Unraveling Their Intricate Mechanisms

Fatty Acid and Lipopolysaccharide Effect on Beta Cells Proteostasis and its Impact on Insulin Secretion

Impact of Brain Fatty Acid Signaling on Peripheral Insulin Action in Mice.

Hepatic Glucagon Action - Beyond Glucose Mobilization

GPCR-mediated effects of fatty acids and bile acids on glucose homeostasis

GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion

Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases

Isosteviol Has Beneficial Effects On Palmitate-Induced Alpha-Cell Dysfunction And Gene Expression

Metabolic Role of GABA in the Secretory Function of Pancreatic β-Cells: Its Hypothetical Implication in β-Cell Degradation in Type 2 Diabetes

Mitochondria to plasma membrane redox signaling is essential for fatty acid β-oxidation-driven insulin secretion

Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.

[Glucagon and glucagon-like peptides the role in control glucose homeostasis. Part I]

Glucagon Potentiates Insulin Secretion Via Beta-Cell Gcgr At Physiological Concentrations Of Glucose

Misrouting of glucagon and stathmin-2 towards lysosomal system of α-cells in glucagon hypersecretion of diabetes

Glucagon Receptor Signaling and Lipid Metabolism

Glucagon and Regulation of Glucose Metabolism

Acute changes in systemic glycemia gate access and action of GLP-1R agonist on brain structures controlling energy homeostasis

Effects of Free Fatty Acids and Glucose on Splanchnic Insulin Dynamics

2-Hydroxylation is a chemical switch linking fatty acids to glucose-stimulated insulin secretion